Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DryShield is a dental medical device company focused on in-treatment patient isolation systems for chairside dental procedures. Its flagship DryShield system integrates high-suction evacuation, saliva management, bite block, tongue shield, and oral pathway protection into a single device intended to improve procedural efficiency, visibility, and patient safety. The company serves the dental care market rather than the biopharma drug-development market, so it does not have a therapeutic pipeline in the traditional biotech sense. DryShield was founded in 2011 in Fountain Valley, California, and was acquired by Solmetex in April 2022. Following the acquisition, the DryShield product line has continued to be marketed commercially through Solmetex.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DryShield.